Free Trial

Alyeska Investment Group L.P. Takes Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Aspen Aerogels logo with Construction background

Alyeska Investment Group L.P. acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 800,000 shares of the construction company's stock, valued at approximately $9,504,000. Alyeska Investment Group L.P. owned approximately 0.98% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. AlphaQuest LLC boosted its stake in Aspen Aerogels by 54.0% in the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after acquiring an additional 3,998 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of Aspen Aerogels in the 4th quarter valued at about $164,000. Connors Investor Services Inc. acquired a new stake in shares of Aspen Aerogels in the 4th quarter valued at approximately $168,000. Journey Strategic Wealth LLC acquired a new stake in shares of Aspen Aerogels in the 4th quarter valued at approximately $178,000. Finally, Ballentine Partners LLC boosted its stake in Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after acquiring an additional 2,565 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ASPN has been the subject of several recent analyst reports. Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Barclays reduced their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a report on Wednesday, February 19th. Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a report on Friday, February 14th. Finally, Craig Hallum reduced their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels currently has an average rating of "Moderate Buy" and a consensus target price of $19.11.

Read Our Latest Stock Report on Aspen Aerogels

Aspen Aerogels Stock Performance

ASPN traded up $0.64 during trading on Friday, hitting $4.95. The stock had a trading volume of 3,835,747 shares, compared to its average volume of 1,934,134. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The company has a 50 day moving average price of $6.08 and a 200-day moving average price of $10.53. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $33.15. The firm has a market cap of $406.42 million, a price-to-earnings ratio of 30.94 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. The business had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. Aspen Aerogels's revenue was down 16.7% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.02) earnings per share. As a group, research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines